This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2023 Jul 1;18(7):930-932.

doi: 10.2215/CJN.0000000000000137. Epub 2023 Apr 24.

Feasibility and Acceptability of SARS-CoV-2 Screening among Patients Receiving Hemodialysis: A Pilot Study

Affiliations

Affiliations

¹ Department of Medicine (Nephrology), Stanford University, Stanford, California.
² Departments of Medicine (Infectious Diseases and Geographic Medicine), and Epidemiology and Population Health, Stanford University, Stanford, California.
³ US Renal Care, Plano, Texas.
⁴ Ascend Clinical Laboratory, Sunnyvale, California.
⁵ Department of Health Policy, Stanford University, Stanford, California.
⁶ Departments of Medicine (Nephrology), and Epidemiology and Population Health, Stanford University, Stanford, California.

PMID: 36976655
PMCID: PMC10356115
DOI: 10.2215/CJN.0000000000000137

Feasibility and Acceptability of SARS-CoV-2 Screening among Patients Receiving Hemodialysis: A Pilot Study

Shuchi Anand et al. Clin J Am Soc Nephrol. 2023.

. 2023 Jul 1;18(7):930-932.

doi: 10.2215/CJN.0000000000000137. Epub 2023 Apr 24.

Authors

Affiliations

¹ Department of Medicine (Nephrology), Stanford University, Stanford, California.
² Departments of Medicine (Infectious Diseases and Geographic Medicine), and Epidemiology and Population Health, Stanford University, Stanford, California.
³ US Renal Care, Plano, Texas.
⁴ Ascend Clinical Laboratory, Sunnyvale, California.
⁵ Department of Health Policy, Stanford University, Stanford, California.
⁶ Departments of Medicine (Nephrology), and Epidemiology and Population Health, Stanford University, Stanford, California.

PMID: 36976655
PMCID: PMC10356115
DOI: 10.2215/CJN.0000000000000137

No abstract available

PubMed Disclaimer

References

1. Weinhandl ED, Gilbertson DT, Wetmore JB, Johansen KL. COVID-19-Associated decline in the size of the end-stage kidney disease population in the United States. Kidney Int Rep. 2021;6(10):2698–2701. doi: 10.1016/j.ekir.2021.07.019 - DOI - PMC - PubMed
1. Dora AV, Winnett A, Jatt LP, et al. Universal and serial laboratory testing for SARS-CoV-2 at a long-term care skilled nursing facility for veterans—Los Angeles, California, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(21):651–655. doi: 10.15585/mmwr.mm6921e1 - DOI - PMC - PubMed
1. Centers for Disease Control and Prevention. COVID-19 by county. 2022. Last Accessed December 1, 2022. https://www.cdc.gov/coronavirus/2019-ncov/your-health/covid-by-county.html
1. Herman C. What makes a screening exam “good”? AMA J Ethics. 2006;8(1):34–37. doi: 10.1001/virtualmentor.2006.8.1.cprl1-0601 - DOI - PubMed
1. Hiremath S, McGuinty M, Argyropoulos C, et al. Prescribing nirmatrelvir/ritonavir for COVID-19 in advanced CKD. Clin J Am Soc Nephrol. 2022;17(8):1247–1250. doi: 10.2215/CJN.05270522 - DOI - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Associated data

Actions
- Search in PubMed
- Search in ClinicalTrials.gov

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal